Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors. Contemp Clin Trials 2026 Feb;161:108205
Date
12/27/2025Pubmed ID
41453520Pubmed Central ID
PMC12987546DOI
10.1016/j.cct.2025.108205Scopus ID
2-s2.0-105027232337 (requires institutional sign-in at Scopus site)Abstract
BACKGOUND: Prostate cancer (PC) incidence and mortality rates are significantly higher among Black/African-American (Black) men compared to men of other race/ethnicities. Comorbidities and compromised quality of life are also greater challenges for this community of men. Many factors drive these differences among which body composition and health behaviors are important, yet modifiable contributors. Lifestyle interventions report beneficial results for PC survivors; however, the inclusion of Black men is critically limited. This paper describes Men Moving Forward (MMF) -a community-based lifestyle intervention for Black men with PC.
METHODS/DESIGN: This trial will randomize (1:1) 200 Black men with PC who completed treatment or are on active surveillance. The 16-week MMF intervention, conducted in partnership with the Milwaukee Recreation system, supports adoption of the American Cancer Society Nutrition and Physical Activity guidelines. Measures of body composition (primary), behavior (diet, physical activity), fitness, quality of life, and biomarkers of general health and PC recurrence risk are collected at baseline, post-intervention and at a 12-month follow-up. The primary hypothesis is that men receiving the MMF intervention will exhibit greater changes in body composition than those in the wait-list control group.
DISCUSSION: The MMF trial addresses an important gap in the current literature, evaluating the potential efficacy of a lifestyle program developed with and for Black men with PC. Outcomes including body composition and biomarkers of general health and PC recurrence risk add to our knowledge and methodologies on health behaviors and PC survivorship. Study results will inform survivorship efforts for this high-risk, underrepresented population. U.S.
CLINICALTRIALS: gov number: NCT03971591, 06.01.2019.
Author List
Awoyinka I, Sheean P, Papanek P, Flynn KE, Bylow K, Kilari D, Gann P, Banerjee A, Stolley MAuthors
Iwalola A. Awoyinka Assistant Professor in the Medicine department at Medical College of WisconsinAnjishnu Banerjee PhD Associate Professor in the Data Science Institute department at Medical College of Wisconsin
Kathryn A. Bylow MD Associate Professor in the Medicine department at Medical College of Wisconsin
Kathryn Eve Flynn PhD Vice Chair, Professor in the Medicine department at Medical College of Wisconsin
Deepak Kilari MD Associate Professor in the Medicine department at Medical College of Wisconsin
Paula Papanek PhD, MPT, LAT, FACSM Associate Professor & Director of Exercise Science in the Exercise Science & Physical Therapy department at Marquette University
MESH terms used to index this publication - Major topics in bold
AgedBody Composition
Cancer Survivors
Diet
Exercise
Health Behavior
Humans
Life Style
Male
Middle Aged
Prostatic Neoplasms
Quality of Life
Randomized Controlled Trials as Topic
Research Design









